FDA Approves Gazyva (obinutuzumab) for Lupus Nephritis
- /
- /
October 2025 FDA approval of Gazyva expands therapeutic options for lupus care The U.S. Food and Drug Administration (FDA) has…
Blog
Articles with Educational information and Resources
Trusted, human-reviewed articles across rheumatological, autoimmune and neurological conditions, for patients and the care-partners.
Stay in the loop
Get new articles as they publish
Join our community and we will send trusted education and updates for your condition.